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Abstract
Wnt proteins comprise a large family of secreted ligands implicated in a wide variety of biological roles. WntD has previously
been shown to inhibit the nuclear accumulation of Dorsal/NF-kB protein during embryonic dorsal/ventral patterning and
the adult innate immune response, independent of the well-studied Armadillo/b-catenin pathway. In this paper, we present
a novel phenotype for WntD mutant embryos, suggesting that this gene is involved in migration of primordial germ cells
(PGC) to the embryonic gonad. Additionally, we describe a genetic suppressor/enhancer screen aimed at identifying genes
required for WntD signal transduction, based on the previous observation that maternal overexpression of WntD results in
lethally dorsalized embryos. Using an algorithm to narrow down our hits from the screen, we found two novel WntD
signaling components: Fz4, a member of the Frizzled family, and the Drosophila Ceramide Kinase homolog, Dcerk. We show
here that Dcerk and Dmulk (Drosophila Multi-substrate lipid kinase) redundantly mediate PGC migration. Our data are
consistent with a model in which the activity of lipid phosphate phosphatases shapes a concentration gradient of ceramide-
1-phosphate (C1P), the product of Dcerk, allowing proper PGC migration.
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Introduction
Signaling pathways such as those activated by the Wnt family of
secreted ligands control a widevariety ofbiological processes.WntD
(Wnt inhibitor of Dorsal, CG8458 and formerly annotated Wnt8) is
a particularly interesting member of this family that is likely specific
to Drosophila [1,2]. WntD inhibits nuclear accumulation of the NF-
kB homolog Dorsal during dorsal/ventral patterning and during
the adult innate immune response. Maternal overexpression of
WntD leads to lethal dorsalization of embryos, while wntD
KO1
mutants display a mild expansion of nuclear Dorsal protein into the
anterior and posterior poles, suggesting that, in vivo, WntD restricts
the region of Dorsal protein activity [3,4]. Furthermore, wntD
KO1
mutant adults exhibit an aberrant innate immune response to
bacterial infection: a subset of Dorsal target genes encoding anti-
microbial peptides is more highly expressed than in WT, before and
after infection. wntD
KO1 mutants also die earlier upon infection with
pathogenic bacteria, suggesting that WntD signaling is critical in
modulating the innate immune response to microbial infection [3].
This increased lethality may be due to upregulation of the TNF
homolog Eiger and a novel gene called Edin in the wntD
KO1 mutants.
Overexpression of Edin is sufficient to induce lethality, and eiger
mutant flies live longer upon Salmonella infection, suggesting that
higher expression of either of these genes is detrimental [5,6].
In follow-up studies on wntD
KO1 mutants we discovered another
role for WntD in development: regulating migration of the
embryonic primordial germ cells (PGC) to the gonad. PGC, also
known as pole cells, are the first cells in the Drosophila embryo to be
specified. They begin their journey at the posterior pole, and
remain outside the embryo proper upon cellularization of the
embryo blastoderm [7]. During gastrulation, the PGC are carried
into the embryo with the invaginating midgut epithelium. Around
stage 9–10, the PGC begin to migrate across the midgut
epithelium, initially dorsally along the midgut epithelium, and
then sort bilaterally. As bilateral sorting proceeds, the PGC begin
to be associated with mesoderm and eventually align with
mesodermal somatic gonadal precursors (SGP) around stage 13.
Around stage 14, the PGC and SGP coalesce to form the
embryonic gonad [7,8].
Although much is known about the cell movements and tissue
interactions along the PGC migratory path, and many genes
required for proper PGC guidance have been discovered, the
identity of specific guidance molecules for the germ cells is yet
unknown. For example, several Drosophila mutants in the 3-
hydroxy-3-methyl-glutaryl-CoA reductase (HMGCR) pathway
display defects in PGC migration, and misexpression of some of
these genes is sufficient to attract PGC to ectopic tissues. These
data suggest that a geranylgeranylated molecule originating in the
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or the geranylgeranylated molecule is secreted and acts as the
attractant itself. However, this attractant has not been identified
[9,10].
Another major mechanism controlling PGC migration is
through the lipid phosphate phosphatases encoded by the Wun
and Wun2 genes. PGC avoid tissues with endogenous or ectopic
Wun or Wun2 expression, and loss of these genes results in highly
disorganized PGC movement [11,12,13]. These studies suggest a
model in which a phospholipid gradient shaped by Wun/Wun2
activity controls PGC migration, either through attraction of
PGC by a phospholipid or repulsion by a non-phosphorylated
lipid. It is yet unclear whether attraction or repulsion is acting
upon the PGC in this model. Furthermore, Wun and Wun2
encode broad-specificity lipid phosphate phosphatases, and it is
unclear what the relevant substrate is in relation to PGC
migration [14,15].
Given the wntD
KO1 mutant phenotype in germ cell migration,
we reasoned that uncovering WntD signal transduction pathway
components might lend insight into the mechanism by which PGC
are attracted to the gonad. Interestingly, WntD likely signals
independently of the canonical Armadillo (Arm)/b-catenin
pathway. Overexpression of WntD in tissues sensitive to increased
levels of Arm signaling fails to produce detectable phenotypes, and
germline mutations in Daxin, a negative regulator of Arm, do not
result in embryonic dorsalization [3] [16]. In order to identify
components of the WntD signal transduction pathway, we
undertook a genetic screen for suppressors and enhancers of
WntD-mediated embryonic dorsalization. Here, we report the
results from the screen, as well as our analysis of two suppressors of
WntD overexpression: Df(1)Sxl-bt, which removes Fz4 (CG4626), a
strong candidate for the WntD receptor; and Df(3R)e1025-14,
which removes Drosophila Ceramide Kinase (Dcerk, CG16708), a
likely downstream effector.
Although our suppressor/enhancer screen is based on the ability
of maternal WntD overexpression to lethally dorsalize embryos
through inhibition of Dorsal protein activity, there are many
examples of a single signaling pathway regulating multiple
biological processes throughout development and homeostasis
[17,18]. It would therefore be unsurprising to find that a single
pathway transducing the WntD signal can affect both dorsal/
ventral patterning and PGC migration. Here, we provide evidence
for ceramide kinase activity in WntD signaling and present a
model in which the WntD pathway controls the production of
ceramide-1-phosphate (C1P), which might be a substrate of Wun
and Wun2 to attract PGC to the gonad.
Results
wntD
KO1 mutants display defects in primordial germ cell
migration
We detected expression of WntD protein in tissues known to
influence PGC migration, such as the invaginating midgut in stage
8 embryos (Figure S1A), and the midgut and gonad in stage 14
embryos (Figure S1B). We therefore wondered whether wntD
KO1
mutant embryos may exhibit a phenotype in migration of
primordial germ cells (PGC) to the gonad. WT and wntD
KO1
mutant (maternal and zygotic) embryos were stained with antibody
directed against the PGC-specific protein Vasa, and PGC that
failed to migrate to the gonad by stage 14–16 were quantified
(Figure 1). Indeed, we observed significantly more mislocalized
PGC in wntD
KO1 mutants than in WT embryos. We also found a
higher frequency of wntD
KO1 embryos with more than 2
mislocalized PGC than in WT embryos (Figure 1D).
A suppressor/enhancer screen to identify WntD pathway
components
It is of interest to determine how the WntD ligand signals to
influence PGC migration and other biological processes. To
identify components of the WntD signaling pathway, we
performed a screen for suppressors and enhancers of the lethality
caused by maternal overexpression of WntD [3]. Briefly, we
generated Act-Gal4/+; UASp-WntD/+ females carrying deficiencies
(heterozygous) from the Bloomington stock center deficiency kit
and mated them to WT males (Figure S2). Progeny of Act-Gal4/+;
UASp-WntD/+ mothers have a low rate of survival to pupal stage,
while introduction of various deficiencies to this genetic back-
ground can enhance or suppress this lethality (Figure 2). Criteria
for categorizing deficiencies as enhancers or suppressors are
described in materials and methods. Final categorization of
deficiencies is shown in Figure 2, in which results organized by
chromosome are shown graphically. Black columns indicate
control crosses with WT or WntD overexpressor mothers. Red
columns indicate suppression, orange columns represent weak
suppression, blue columns and regions with no columns (no
survival to pupal stage) represent no effect, and regions with no
columns and a green dot represent enhancement. The full data set
in Microsoft Excel format is available upon request.
As the lethality phenotype is a readout of signaling by the Dorsal
transcription factor, suppressors and enhancers revealed by the
screen might be due to deletion of genes in the Toll pathway as
well as the WntD pathway. If deficiencies removing positive
regulators of the Toll pathway were categorized as enhancers, this
enhancing effect may be due to modification of Toll signaling and
not specific to WntD signaling. However, we found that
deficiencies removing the positive regulators of Toll signalling
Toll, Tube, Pelle and Myd88 do not enhance WntD-mediated
Figure 1. wntD
KO1 mutant embryos display increased numbers
of mislocalized primordial germ cells. A–B. Embryos stained with
anti-Vasa antibody to mark primordial germ cells (PGC). A. Represen-
tative wild-type (WT) embryo, stage 14. B. Representative wntD
KO1
embryo, stage 14. While the majority of PGC have reached the gonad
and coalesced with somatic cells, arrows indicate PGC that have failed
to migrate properly by this stage. C. Quantification of average
mislocalized PGC per embryo, stage 14–16. Error bars represent
standard error of the mean (SEM). Asterisk indicates P,5610
25 by
Student’s T-test. D. Analysis of the number of embryos with
mislocalized PGC. There is an increase in the proportion of embryos
with more than 2 mislocalized cells in wntD
KO1 compared to WT.
doi:10.1371/journal.pone.0026993.g001
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screen are likely specific to the WntD pathway (Figure 2F).
As mentioned above, previous experiments suggested no role for
the b-catenin pathway in WntD signaling. To confirm this result
using independent methodology, we examined deficiencies from
the screen that remove regulators of Wnt-b-catenin signaling. If
WntD signals via a b-catenin-dependent mechanism, deficiencies
removing positive regulators of Wnt-b-catenin signaling would
suppress WntD-mediated lethality and deficiencies removing
inhibitors of Wnt-b-catenin signaling would enhance WntD-
mediated lethality. However, we found that the deficiency
Df(3R)L127, which removes the inhibitor of b-catenin signaling
Daxin (as well as dozens of other genes), was categorized as a
suppressor (Figure 2F). Furthermore, the dsh
3 null allele failed to
suppress WntD overexpression (data not shown), suggesting that
lethal embryonic dorsalization by WntD signaling is not mediated
by Dsh or Daxin in their Wnt-b-catenin roles.
To identify genes removed by suppressor and enhancer
deficiencies that are strong candidates to encode WntD pathway
components, an algorithm was written that assigned a score to
each gene based on several criteria. Genes with Gene Ontology
(GO) terms consistent with a role in WntD signal transduction or
control of Dorsal activity such ‘‘signal,’’ ‘‘wnt,’’ ‘‘dorsal,’’ ‘‘toll,’’
‘‘immune,’’ ‘‘kinase,’’ and ‘‘phosphatase’’ received one point per
GO term (up to three points total). Additionally, genes expressed
at 2-fold different levels in wntD
KO1 mutant adults infected or
uninfected, versus WT adults infected or uninfected received one
point (‘‘WntD/yw’’ and ‘‘Listeria WntD/yw’’ columns) [5]. Lastly,
for a gene to suppress or enhance WntD signaling in this assay it
must be provided maternally to the embryo. Genes expressed
maternally received two points; genes not expressed maternally
were penalized two points. Strong candidates identified using this
method are shown in Table S1. In this paper, we further
characterize two deficiencies that strongly suppress WntD
overexpression: Df(1)Sxl-bt and Df(3R)e1025-14 (Figure 2F).
WntD signals through Fz4
The deficiency Df(1)Sxl-bt is predicted to remove Fz4 (a likely
WntD signaling component) and at least 29 other genes (Flybase).
In order to confirm that Fz4, rather than another gene removed by
the deficiency, suppresses WntD overexpression, we generated
Df(1)Sxl-bt/+; Act-Gal4/+; UASp-WntD/UASp-Fz4 females and
mated them to WT males, comparing survival of progeny to a
WT cross, as well as WntD overexpressors with and without one
copy of the Df(1)Sxl-bt deficiency chromosome as before. We
found that Fz4 expression restores WntD-mediated lethality,
suggesting that loss of Fz4 specifically suppresses WntD overex-
pression. Overexpression of Fz4 alone shows no lethality
(Figure 3A).
To further examine the role for Fz4 in WntD signal
transduction, we wished to generate Fz4 null alleles. We therefore
performed transposase-mediated excision of P{GSV2}GS7412, a
P-element inserted 217 base pairs upstream of the Fz4 start codon
(Figure S3B). We recovered 55 excisions and screened for large
deletions by Southern blot (a subset are shown in Figure S3C). The
locations of the EcoRI sites at the Fz4 locus used for Southern blot
screening are shown in Figure S6.
Two homozygous viable and fertile excision lines, fz4
3-1 and
fz4
25-1, were analyzed further. Sequence analysis revealed that
both alleles are large deletions (Figure S3B). Quantitative RTPCR
showed that both alleles are null for mRNA (Figure 3C).
In order to further confirm the role for Fz4 in WntD signal
transduction, we tested the novel fz4
3-1 and fz4
25-1 null alleles for
the ability to dominantly suppress WntD overexpression. We
compared survival of progeny from WT and WntD overexpressor
females with and without one copy of each of the Fz4 mutant
alleles Df(1)Sxl-bt, fz4
P{GSV2}, fz4
3-1, and fz4
25-1. We found that
heterozygosity for each of these Fz4 mutant alleles tested suppress
WntD overexpression (Figure 3B).
Based on the genetic interactions between Fz4 and WntD,w e
tested for direct binding of purified, soluble proteins by
immunoprecipitation of protein G beads. We found that protein
G beads highly depleted the purified Fz4::IgG fusion protein and
IgG control protein from the supernatant (Figure 3D, lanes 2 and
4 of lower blot), and the Fz4::IgG bead precipitation was highly
enriched for purified WntD over the IgG bead precipitation
(Figure 3D, compare lanes 5 and 6 of upper blot), showing that
WntD and the cysteine rich domain (CRD) of Fz4 specifically
bind, in agreement with previous data showing that a membrane-
bound form of WntD binds to a soluble Alkaline-Phosphatase-Fz4
fusion protein [19].
WntD signals through Dcerk and Dmulk to control PGC
migration
A second intriguing suppressor from the screen is Df(3R)e1025-
14. This deficiency is predicted to remove CG16708, encoding the
Drosophila homolog of Ceramide Kinase (hereafter referred to as
Dcerk) [20,21,22], as well as 24 other genes (Flybase). Human
Ceramide kinase (Cerk) catalyzes the phosphorylation of the
sphingolipid ceramide to form ceramide-1-phosphate [22].
Ceramide and ceramide phosphate signaling have been implicated
in a variety of biological processes, including apoptosis, inflam-
mation, and cell proliferation [23,24]. Because our algorithm for
ranking genes identified in the screen assigned Dcerk a score of 3
(Table S1), and given the abundance of evidence that phospholipid
metabolism controls PGC migration, we thought it likely that
mutations in Dcerk could disrupt proper PGC localization to the
gonad [11,12,14].
To first confirm that haploinsufficiency of Dcerk itself confers the
suppressive activity to Df(3R)e1025-14 (Figure 2F), we obtained the
homozygous viable and fertile P-element P{GT1}BG01100
(hereafter referred to as dcerk
P{GT1}), inserted in the predicted first
intron of Dcerk. We mated Act-Gal4/+; UASp-WntD/+ females, Act-
Gal4/+; UASp-WntD/dcerk
P{GT1} females and WT females to WT
males and compared survival of their progeny (Figure 4). We
Figure 2. A genetic screen reveals 75 modifier deficiencies that are likely specific to the WntD pathway. A–D. Graphical representation
of pupal counts from primary screen. Colored bars represent counts of progeny from WntD overexpressor females also carrying deficiency
chromosomes. Black columns are WT and WntD overexpressor controls. Red columns represent deficiencies characterized as suppressors; orange
columns represent deficiencies characterized as weak suppressors; blue columns represent deficiencies having no effect; green dots represent
deficiencies characterized as enhancers. Regions with no columns and no green dot are deficiency crosses resulting in no pupae that are
characterized as having no effect. A secondary screen described in Materials and Methods contributed to these final characterizations. A.
Chromosome 1 results. B. Chromosome 2 results. C. Chromosome 3 results. D. Chromosome 4 results. E. Summary of deficiencies tested and
characterizations. F. Selected deficiencies from the screen that remove interesting genes (Fz4, Dcerk); components of the Toll signaling pathway (Toll,
Tube, Pelle, Myd88); and Daxin, a component of the Wnt/Armadillo signaling pathway. It is important to note that these deficiencies remove the
aforementioned genes as well as dozens of other genes.
doi:10.1371/journal.pone.0026993.g002
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P{GT1} allele strongly suppresses WntD
overexpression, similar to the original deficiency.
To confirm that the P-element insertion at the Dcerk locus and
not a linked mutation causes suppression of WntD overexpression,
we performed transposase-mediated P-element excision. By
sequencing the region surrounding the P{GT1}BG01100 insertion
site we discovered that one excision allele, dcerk
X35, has 38 bases of
the P-element remaining at the locus (data not shown). We tested
whether dcerk
X35 can suppress WntD overexpression by generating
Act-Gal4/+; UASp-WntD/dcerk
X35 females and comparing survival
of their progeny to WT females, Act-Gal4/+; UASp-WntD/+
females, and Act-Gal4/+; UASp-WntD/dcerk
P{GT1} females that had
been mated to WT males. We found that, while the original
dcerk
P{GT1} insertion suppresses WntD overexpression, the near-
precise excision dcerk
X35 failed to suppress, suggesting that dcerk
X35
retains wild-type activity, and Dcerk specifically is required for
WntD signaling-mediated embryonic lethality (Figure 4).
When we tested homozygous dcerk
P{GT1} mutant embryos for a
PGC phenotype as seen in wntD
KO1 mutants (Figure 1), we failed to
see an increase in mislocalized PGC compared to WT (Figure 5).
Hypothesizing redundancy between several lipid kinases
(Figure 6A), we tested mutants in the lipid kinase genes
Diacylglycerol kinase (dgk
f03609), Sphingosine kinase 2 (sk2
KG05894),
CG31873
3414 [25], as well as four deficiencies removing Sphingosine
kinase 1 (Sk1)-Df(1)BSC287, Df(1)BSC288, Df(1)BSC722, and
Df(1)ED7067 - for the ability to dominantly suppress WntD
overexpression, as before. We found that heterozygosity for either
the dcerk
P{GT1} allele or the CG31873
3414 allele strongly suppressed
Figure 3. Confirmation of Fz4 as a WntD receptor. A–B. Error bars represent SEM. A. Suppression and rescue of WntD overexpression. Maternal
overexpression of WntD results in low viability of progeny. Maternal overexpression of WntD in flies carrying Df(1)Sxl-bt results in high viability of
progeny. Maternal co-overexpression of WntD and Fz4 in flies carrying Df(1)Sxl-bt restores low viability of progeny. Maternal overexpression of Fz4
alone has no associated lethality of progeny. B. Maternal overexpression of WntD results in low viability of progeny. Maternal overexpression of WntD
in flies carrying Df(1)Sxl-bt, fz4
P{GSV2}, fz4
3-1,o rfz4
25-1 results in high viability of progeny. C. Comparison of Fz4 mRNA expression in WT, fz4
P{GSV2}, fz4
3-1,
and fz4
25-1 adult flies. D. Co-immunoprecipitation of WntD and the cysteine-rich domain (CRD) of Fz4. Top panel: anti-WntD blot. WntD is highly
enriched in the Fz4::IgG precipitation lane. Bottom panel: anti-IgG blot. The majority of IgG and Fz4::IgG proteins were bound to the protein G
sepharose beads.
doi:10.1371/journal.pone.0026993.g003
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allele tested (Figures 6B and S4). CG31873 encodes a homolog of
mouse Multi-substrate Lipid kinase (MuLK, also known as
acylglycerol kinase, Agk) reported to phosphorylate ceramide in
vitro [26]. The CG31873
3414 allele is an insertion of a piggyBac
transposon containing splice acceptors, and stop codons in all
three reading frames, which generates a nonsense allele and is
described in [25]. We hereafter refer to CG31873 as Dmulk.
When we labeled PGC in maternal and zygotic double mutant
dmulk
3414; dcerk
P{GT1} embryos using the Vasa antibody, we found a
significant increase in the number of mislocalized PGC in stage
14–16 mutant embryos compared to WT (Figure 7, compare A vs.
E). Furthermore, neither single mutant alone displayed a
significant increase in mislocalized PGC (Figures 5C and 7B),
nor did dmulk
3414/CyO; dcerk
P{GT1} embryos carrying a single wild
type, paternally inherited allele of Dmulk (Figure 7C). dcerk
X43 flies
express wild-type levels of Dcerk transcript (data not shown); we
therefore consider dmulk
3414; dcerk
X43 flies to be equivalent to
mutants carrying the dmulk
3414 allele alone (Figure 7B). Impor-
tantly, we find that wntD
KO1 mutant and dmulk
3414; dcerk
P{GT1}
double mutant embryos display decreased numbers of PGC
localized at the gonad when compared to WT, while total
numbers of PGC within the embryo are indistinguishable from the
WT, suggesting that the mislocalized cells are truly failing to
migrate properly, rather than simply being ‘‘extra’’ cells
(Figure 7H).
Dcerk and Dmulk regulate Ceramide-1-Phosphate levels
in vivo
Previous studies have shown that Dcerk is required for wild-type
levels of ceramide-1-phosphate (C1P), suggesting that the gene
encodes a bona fide ceramide kinase [21]. Our data showing that
Dcerk and Dmulk redundantly control PGC migration implies
that C1P, the product of ceramide phosphorylation, plays a role in
guiding PGC to the gonad. This would require that Dmulk also
encodes a protein with ceramide kinase activity. To test this
possibility, we collected overnight egg lays from WT, UASp-Dcerk/
CyO; Act-Gal4/TM6B (maternal Dcerk overexpression), and UASp-
Dmulk/CyO; Act-Gal4/TM6B (maternal Dmulk overexpression)
incrosses and measured C1P levels, normalized to phosphatidyl-
choline levels. Upon Dcerk and Dmulk overexpression, we
detected a 4.2-fold and 3.3-fold increase in embryonic C1P levels
over WT levels respectively, showing that both Dcerk and Dmulk
are sufficient to increase C1P production (Figure 8). Full results
showing the effects of Dcerk and Dmulk overexpression on C1P
molecular species are shown in Figure S5. Given that the mouse
homolog of Dmulk is a bona fide ceramide kinase [26], our data
strongly suggest that Dmulk likely also functions as a ceramide
kinase.
Figure 4. Confirming the effect of Dcerk mutation on WntD
signaling. Comparing the survival of progeny of different maternal
genotypes, as assayed by embryonic hatching. Maternal WntD
overexpression results in low viability of progeny. Maternal WntD
overexpression in flies also carrying a p-element insertion allele,
dcerk
P{GT1}, results in high viability of progeny. Maternal WntD
overexpression in flies carrying a near-precise excision allele, dcerk
X35,
results in low viability of progeny.
doi:10.1371/journal.pone.0026993.g004
Figure 5. dcerk
P{GT1} mutant embryos fail to phenocopy the wntD
KO1 PGC phenotype. A–C. Embryos stained with anti-Vasa antibody to
mark PGC. A. Representative WT embryo, stage 16. B. Representative wntD
KO1 embryo, stage 16. Arrows indicate PGC that have failed to migrate
properly by this stage. C. Representative dcerk
P{GT1} embryo, stage 15. D. Quantification of average numbers of mislocalized PGC per embryo, stage
14–16. Error bars represent SEM. Asterisk indicates P,6610
210 by Student’s T-test. E. Analysis of the number of embryos with mislocalized PGC.
There is an increase in the proportion of embryos with more than 2 mislocalized cells in wntD
KO1 compared to WT. dcerk
P{GT1} more closely resembles
WT than wntD
KO1.
doi:10.1371/journal.pone.0026993.g005
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Here, we report on a suppressor/enhancer screen designed to
identify members of a novel signaling pathway transducing the
WntD ligand. Using the methods described above, we narrowed
our initial list of 75 modifiers down to 43 genomic regions likely to
encode members of the WntD pathway. We further investigated
the suppressor deficiencies Df(1)Sxl-bt and Df(3R)e1025-14.
Figure 6. A mutation in the D. melanogaster Mulk homolog strongly suppresses WntD overexpression. A. Phylogenetic tree of Homo
sapiens (Hs) and Drosophila melanogaster (Dm) lipid kinases. DmSk1 and 2, HsSphk1 and 2 are sphingosine kinases. DmCerk and HsCERK are ceramide
kinases. DmMulk and HsMuLK are multi-substrate lipid kinases. Dm and HsDgk are diacylglycerol kinases. B. Effect of lipid kinase alleles on WntD
signaling as assayed by survival to pupal stage. Maternal WntD overexpression results in low viability of progeny. Maternal WntD overexpression in
flies carrying either dcerk
P{GT1} or dmulk
3414 results in high survival of progeny. Error bars represent SEM.
doi:10.1371/journal.pone.0026993.g006
Figure 7. dcerk
P{GT1}; dmulk
3414 double mutant embryos phenocopy the wntD
KO1 PGC phenotype. A–E. Representative embryos, stage 14–
16, stained with anti-Vasa to visualize PGC. A. WT. B. Embryo double mutant for dmulk
3414, a null allele, and dcerk
X43, an excision allele expressing WT
levels of Dcerk mRNA (data not shown). This genotype is essentially a dmulk
3414 alone control. C. Embryo heterozygous for dmulk
3414 and
homozygous for dcerk
P{GT1}. D. wntD
KO1. E. Embryo double homozygous mutant dmulk
3414; dcerk
P{GT1}. F–H. Quantification of PGC mislocalization in
stage 14–16 embryos of genotypes: A - WT. B - dmulk
3414; dcerk
X43.C-dmulk
3414/CyO; dcerk
P{GT1}.D-wntD
KO1.E-dmulk
3414; dcerk
P{GT1}. F. Average
numbers of mislocalized PGC per stage 14–16 embryo. Error bars represent SEM. G. Analysis of the number of stage 14–16 embryos with mislocalized
PGC. H. Analysis of total numbers of PGC per stage 14–16 embryos. Mislocalized embryos are failing to migrate correctly, rather than failing to die.
Error bars represent SEM.
doi:10.1371/journal.pone.0026993.g007
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has long been a strong candidate for the WntD receptor, given
previous evidence that the two proteins will bind [19]; however,
until now evidence of a functional interaction has been lacking.
We rescued the suppression by Df(1)Sxl-bt by co-overexpressing
Fz4 and confirmed that mutant alleles of Fz4 can suppress WntD
overexpression, strengthening the idea that WntD signals through
Fz4 in vivo. No other biological role has previously been ascribed to
Fz4, suggesting that this may be the first Wnt-Fz interaction
dedicated to activating a b-catenin-independent pathway. Indeed,
the Fz4 amino acid sequence is quite different from other
members of the Fz family (data not shown), suggesting an
interesting signaling paradigm involving an interaction between
the most divergent Wnt family member and the most divergent Fz
family member.
An outstanding question is whether the receptor Fz4 contributes
to PGC guidance. When we examined PGC migration in fz4
3-1
mutant embryos, we did not observe an increase in mislocalized
cells when compared to WT (data not shown). One possible
explanation for this is that, like the ceramide kinases Dcerk and
Dmulk, Fz4 acts redundantly with another receptor to mediate
PGC guidance. Alternatively, we cannot exclude the possibility
that WntD activates different receptors to regulate D/V pattern-
ing and PGC migration. Further experimentation is required to
more fully understand the biological roles of WntD/receptor
interactions.
The second suppressor deficiency examined, Df(3R)e1025-14,i s
predicted to remove approximately 25 genes. Here, our algorithm
allowed us to focus on a gene removed by the deficiency called
Dcerk. We found that the P-element insertion mutant dcerk
P{GT1}
strongly suppressed WntD overexpression and that near-precise
excision of the P-element abrogated the suppression, confirming
the role of Dcerk in WntD signaling.
Given the role of Dcerk in lipid metabolism [21,22], and the
role of lipid metabolism in Drosophila PGC migration [11], we were
interested to further explore the role of WntD-Dcerk signaling in
this process. While wntD
KO1 mutants display a defect in migration
of PGC to the gonad, dcerk
P{GT1} mutants do not. However, we
identified a Drosophila gene homologous to mouse MuLK,
CG31873/Dmulk, which we hypothesized would compensate for
loss of Dcerk because mouse Mulk can phosphorylate ceramide in
vitro [26]. Indeed, embryos carrying strong loss of function alleles
of both Dmulk and Dcerk display defective PGC migration. In
agreement with this functional redundancy, we showed that
expression of either Dcerk or Dmulk is sufficient to increase
embryonic C1P levels, strongly suggesting that both Dcerk and
Dmulk are ceramide kinases. Further experiments are required to
directly test whether WntD signaling through these proteins
regulates C1P metabolism.
These findings may shed light on previous observations
regarding the influence of phospholipids on germ cell migration.
Studies on Wun and Wun2, genes encoding lipid phosphate
phosphatases, have generated a model in which PGC travel up a
concentration gradient of a phospholipid. It is currently unclear
whether PGC are attracted to the phospholipid or repelled by the
non-phosphorylated version; the identity of the lipid/phospholipid
is also not known [27]. Wun and Wun2 are broad-specificity
phosphatases, and no lipid kinase alleles have previously been
reported with PGC guidance defects in Drosophila. Our data are
the first to indicate a role for a specific phospholipid in PGC
migration and we speculate that C1P may be a relevant substrate
for Wun activity in this process.
Both Dmulk and Dcerk are expressed in the midgut and hindgut
starting around stage 11 of embryogenesis (BDGP in situ
homepage http://insitu.fruitfly.org/cgi-bin/ex/insitu.pl). One
may expect that a PGC attractant would be synthesized in the
PGC target tissue. However, in this model, C1P must be
synthesized and secreted from the midgut and hindgut and must
diffuse readily throughout the embryo. Wun and Wun2 phospha-
tase activity in the gut, central nervous system, and epidermis
generates a gradient of C1P such that C1P in these tissues is
dephosphorylated to form ceramide, leaving the highest concen-
tration of C1P in the lateral mesoderm, where no Wun or Wun2 is
expressed. While most studies on C1P have described intracellular
signaling roles for the molecule, there is evidence that C1P is
readily secreted from bone marrow-derived macrophages
(BMDM), providing further evidence that C1P could be used as
a secreted guidance molecule in Drosophila [28]. We hypothesize a
model in which WntD expression in the embryonic midgut
stimulates the kinase activity of Dmulk and Dcerk, thereby
providing C1P as a PGC chemoattractant.
One possible weakness in this model is that, if all ceramide
kinase activity were removed from the embryo, it might be
expected that no C1P would be generated. If C1P were the
phospholipid guiding PGC to the gonad, a very strong phenotype
would be observed, as is the case in strong wun, wun2 mutants [29].
However, the phenotype in dmulk
3414; dcerk
P{GT1} mutants is weak
in comparison (Figure 7). This may be explained by the fact that
the Dcerk allele used in this study is not a complete null; adult
dcerk
P{GT1} flies express approximately 20% of wild-type levels of
Dcerk mRNA (data not shown). Furthermore, in dmulk
3414;
dcerk
P{GT1} double mutant adults, C1P levels are reduced only 2-
fold compared to WT (data not shown). If this is also true in
embryos, it likely explains why this comparatively weak phenotype
is observed. It is possible that true dmulk; dcerk double null embryos
would have completely disrupted PGC migration.
It is also possible that C1P can be generated via a mechanism
besides ceramide phosphorylation, and true dmulk; dcerk double
null embryos would still have significant levels of C1P. Indeed,
when Cerk null mice were generated, it was found that, while
Figure 8. Analysis of embryonic ceramide-1-phosphate levels.
HPLC-MS quantifications of C1P levels in embryos derived from WT
cross, incross of UASp-Dcerk/CyO; Act-Gal4/TM6B (maternal Dcerk
overexpression), and incross of UASp-Dmulk/CyO; Act-Gal4/TM6B
(maternal Dmulk overexpression). C1P measurements were made in
triplicate and normalized to phosphatidylcholine levels. We observed a
4.2-fold increase in C1P levels upon Dcerk overexpression and a 3.3-fold
increase in C1P levels upon Dmulk overexpression.
doi:10.1371/journal.pone.0026993.g008
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2/2 BMDM have no detectable ceramide kinase activity,
cellular levels of C1P were approximately 25% those of wild-type
cells [28]. These data suggest there is indeed a ceramide kinase-
independent source of C1P in mice; it is likely that this is also the
case in other organisms. There are currently no data suggesting a
mechanism for this in mouse or Drosophila; however, some
arachnid, bacteria and fungus species express a Sphingomyelinase
D (SmaseD) protein capable of metabolizing sphingomyelin
directly into C1P [30]. While a BLAST search of the Drosophila
genome reveals no clear SmaseD homologs, we believe it possible
that this type of Smase activity may be encoded by genes not
apparently related evolutionarily to SmaseD. In this case, even in
the complete absence of ceramide phosphorylating activity, a
significant amount of C1P may be available for the generation of a
gradient by Wun and Wun2 activity. This hypothetical ceramide-
kinase-independent source of C1P would also explain the
comparatively weak phenotype observed in wntD
KO1 embryos.
It is interesting to note that studies have shown that Wun2 can
dephosphorylate phosphatidic acid (PA) and lysophosphatidic acid
(LPA), but not C1P [14,15]. However, mammalian homologs of
Wun can dephosphorylate C1P, as well as S1P, PA and LPA,
raising the possibility that Wun and Wun2 can as well [15,31]. If
this is true, it is unclear why studies have failed to show Wun or
Wun2 activity against C1P. However, given the fact that the
majority of Drosophila sphingolipids contain a 14-carbon backbone,
while mammalian and commercially-synthesized sphingolipids
contain an 18-carbon backbone, we believe it to be likely that
Drosophila proteins have decreased affinity for commonly available
sphingolipid reagents [32]. Furthermore, we cannot exclude the
possibility that Wun activity generates a gradient of multiple
different phospholipids used in PGC guidance. It will be
interesting to see in the future if further experimentation can
address this question.
While vertebrates do not express a WntD ortholog, studies of
Drosophila germ cell migration may lend insight into mechanisms of
vertebrate cell migration. Granado et al. suggest that C1P induces
macrophage migration, although the effect appears to be much
weaker than that induced by S1P [33]. Further experimentation in
both mammalian and Drosophila systems may reveal similarities in
how a gradient of C1P regulates migration of a variety of cell
types.
We have presented here the results of an unbiased genetic
screen aimed at identifying genes in a novel signaling pathway that
transduces the WntD signal. We present the first evidence of a
functional interaction between WntD and its receptor Fz4, and
identify a novel downstream effector, Dcerk. We further
hypothesized that the same transduction mechanism is used to
influence dorsal/ventral patterning, the adult innate immune
response, and PGC migration. Indeed, we present evidence that
two ceramide kinases redundantly mediate the effect of WntD on
both dorsal/ventral patterning and PGC migration. Further
experimentation will determine whether this pathway also impacts
the immune response. Interestingly, our unbiased screen led us to
a line of experimentation suggesting a role for ceramide-1-
phosphate in PGC migration, the first evidence for a specific
phospholipid in this process. Further studies should directly test
whether C1P represents the long-unknown substrate for Wun and
Wun2 in PGC migration.
Materials and Methods
Embryonic Antibody staining
Embryos were removed from agar collection caps with a
paintbrush and dechorionated in 50% bleach for 5 minutes,
followed by rinsing in cold water. Embryos were then fixed in 4%
paraformaldehyde and heptane, devitellinized by methanol/
heptane, and stained with antibodies using standard protocols.
Antibodies and dilutions used were: rabbit anti-Vasa 1:1000–
1:2000 (gift, Yuh Nung Jan) [34]; rabbit anti-WntD 1:500 [3];
mouse anti-b-galactosidase 1:200 (Promega).
Screen crosses and general husbandry
Flies were maintained under standard conditions unless
otherwise noted. WT flies are yw.
For the suppressor/enhancer screen, Act-Gal4/CyO; UASp-
WntD/Tm6B males were mated to virgin females heterozygous
for a single deficiency from the Bloomington deficiency kit (or
WT virgins as control). After 5 days at 25uC the crosses were
shifted to 28uC. Upon eclosion, 5–6 Act-Gal4; UASp-WntD virgin
females carrying one deficiency chromosome were mated to WT
males and progeny surviving to pupae were quantified after 10–
11 days.
For the first pass of analysis, when crosses gave rise to more than
zero but fewer than 25 progeny that survive to pupal stage the
deficiencies were categorized as having no effect. When crosses
gave rise to more than 25 progeny that reached pupal stage, the
deficiencies were initially categorized as suppressors. Exceptions
were made for several crosses resulting in fewer than 25 pupae
when many larvae were observed; these deficiencies were also
categorized as suppressors. When crosses resulted in no churning
of the media, indicating zero survival to larval stage, the
deficiencies were categorized as enhancers. Full results are
available in Microsoft Excel format.
Putative suppressors were subjected to a secondary, more
quantitative screen in which the above crosses were repeated and
embryonic hatching to first-instar larvae was quantified. Crosses
giving rise to embryos with a hatch rate from 1–5% were
categorized as having no effect. Crosses with hatch rates from 6–
19% were categorized as weak suppressors. Crosses with hatch
rates greater than or equal to 20% were categorized as strong
suppressors.
To rule out the possibility that significant lethality indicat-
ing enhancement of WntD overexpression could be due to
reduced viability associated with the deficiency itself, rather
than enhancement of WntD signaling, females carrying the
deficiency plus either the Act-Gal4 or UASp-WntD transgenes,
but not both (and therefore not overexpressing WntD), were
m a t e dt oW Tm a l e sa n ds u r v i v a lo fp r o g e n yw a sa s s a y e d .
Deficiencies conferring significant lethality were categorized
as ‘‘non-specific enhancers’’ and were excluded from further
analysis.
WntD suppression by hatch assay
To assay suppression of WntD overexpression by embryonic
hatch assay, crosses were performed as described above, but
matings between Act-Gal4; UASp-WntD virgins carrying a deficien-
cy and WT males were placed in crossing cages. After 24 hours of
embryo collection, collection caps were removed and embryos
were aged for 24 hours. Embryos hatching to first-instar larvae
were then quantified.
Generation of Fz4 null alleles
Females homozygous for P{GSV2}fz4
GS7412 were mated to
males carrying a D2–3 transposase insertion. P{GSV2}fz4
GS7412;
D2–3 males were then mated to virgin females carrying the
Binsinscy balancer. White-eyed excision/Binsinscy progeny were
mated to Binsinscy males to establish stable stocks.
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Flies carrying the dcerk
P{GT1} allele and a D2–3 transposase
transgene were mated to TM3 balancer flies and the progeny were
screened for loss of the w
+ marker.
Southern Blot
For genomic DNA isolation, 15 adult females of each genotype
(WT, P{GSV2}fz4
GS7412, P{GSV2}fz4
GS7412/Binsinscy, and homo-
zygous or Binsinscy-balanced P{GSV2}fz4
GS7412 excisions) were
crushed with a Kontes pestle in 75 mL lysis buffer (100 mM Tris
pH 8.8, 100 mM EDTA, 1% SDS). An additional 225 mL buffer
was added and samples were further homogenized. Samples were
then incubated at 72uC for 30 min. and 66 mL KOAc (5 M) was
added. Samples were incubated for 30 min. on ice, followed by
centrifugation at 20,8006g for 15 min. at 4uC. The supernatant
was transferred to another tube and centrifuged again. The
supernatant was again transferred and one volume isopropanol
was added. The samples were centrifuged again for 5 min at room
temperature to precipitate genomic DNA. Pellets were washed
with 70% ethanol and centrifuged once more. The pellets were
briefly allowed to air-dry and resuspended in 105 mL TE, and
incubated for several minutes at 37uC to dissolve.
The entire genomic DNA preparation was digested overnight at
37uC with EcoRI and subjected to electrophoresis through
duplicate 0.7% agarose gels. DNA was transferred to Hybond
XL membranes (GE Healthcare) overnight by alkaline transfer in
denaturation buffer (0.5 M NaOH, 1.5 M NaCl). Following
transfer, membranes were incubated for 30 min. in neutralization
buffer (0.5 M Tris pH 6.0, 1.5 M NaCl), washed twice in 2xSSC,
and pre-hybridized in Rapid-Hyb buffer (GE Healthcare) for
30 min at 65uC.
Probes were generated from genomic DNA by PCR using
primers ‘‘sthrn probeC Fw’’ (59- gatctatagcatatctcacca-39) and
‘‘sthrn probeC Re’’ (59- tcaccgtggacggactgtcca-39). Probes were
labeled with 32P alpha-dCTP (Perkin Elmer) using the Rediprime
II Random Prime Labeling System (GE Healthcare) according to
the manufacturer’s instructions. Membranes were incubated
overnight at 65uC with probes in Rapid-Hyb buffer, and then
washed for 20 min. at room temperature in 2xSSC, 0.1% SDS;
15 min. at 65uC in 0.5xSSC, 0.1%SDS; and 15 min. at 65uCi n
0.1xSSC, 0.1% SDS. Hyperfilm MP (GE Healthcare) was exposed
to membranes at 280uC.
Locations of EcoRI sites with respect to the P{GSV2} insertion
and Fz4 start codon are indicated in Figure 6.
PCR analysis of Fz4 mutant alleles
Pfu Ultra II Fusion HS DNA Polymerase (VWR) was used to
PCR amplify the fz4
3-1 and fz4
25-1 loci. Primers Fz4excscreenFw1
(59-gctgacttgcctcttgtagag-39) and Fz4excscreenRe1 (59-gacgagttgc-
ttggtgagatatg-39) were used to amplify the fz4
3-1 locus. Primers
Fz4PscreenFw1 (59- ggaactggcactggggttgcc-39) and Fz4PscreenRv1
(59- gatcgttttcgggttaatccc-39) were used to amplify the fz4
25-1 locus.
PCR products were submitted for sequencing by Elim Biopharm
(Hayward, CA), revealing that fz4
3-1 is a major deletion of 2013 bp
and a minor deletion of 18 bp located 9 base pairs upstream of the
majordeletionandthat fz4
25-1isa 1042 bpdeletioninthepromoter
region (Figure S3B).
Generation of transgenic lines
Primers NOT1CG16708 (59-aaggaaaaaagcggccgcatgacgcagac-
caagcagcca-39) and Xba1CG16708 (59-agtctagactagtccttgcagcag-
cagta-39) were used to amplify the Dcerk coding region. Primers
KpndMuLKFwd (59-gaggtaccatgaattatttaagagtaattc-39) and Xbad
MuLKRev-stop (59-attctagatcaacaaaaaactttaatagc-39) were used to
amplify the CG31873/Dmulk coding region. PCR products were
purified, digested, and ligated into UASp vector. UASp expression
vectors were co-injected with a transposase expression vector into
yw embryos using a pulled-glass needle.
Quantitative RT-PCR
Primers dCERKRTPCRFwd2 (59-gcatctcccgttacagtca-39) and
dCERKRTPCRRev2 (59-aattcccttgtgcgatatacctcta-39) were used
to detect Dcerk transcripts. Primers fz4RTfwd1 (59-aaacgggcaac-
gatcac-39) and fz4RTrev1 (59-gactccaagggccatgt-39) were used to
detect Fz4 transcripts. Primers RpS15AFwd2 (59-ctctggcggcat-
catgga-39) and RpS15ARev1 (59-gttggttgcatggtcggtga-39) were
used to detect RpS15A transcripts.
To purify mRNA, 6 adult females of each genotype were
homogenized in 150 mL Trizol (Invitrogen) using a Kontes pestle.
An additional 150 mL Trizol was added and flies were homoge-
nized some more. Thereafter, the standard Trizol protocol was
followed.
cDNA was synthesized using a Thermoscript kit (Invitrogen)
using included oligo-dT primer and standard protocols. Quanti-
tative PCR was performed using Sybr Green PCR master mix
(Applied Biosystems) on a Step One Plus thermocycler (Applied
Biosystems). Fz4 mRNA levels were normalized against RpS15A
mRNA levels.
Ceramide-1-phosphate quantifications
Prior to lipid extractions, Drosophila embryos were collected on
agar caps using standard methods, dechorionated in 50% bleach,
and washed several times in methanol. Embryos were stored at
220uC in methanol until lipid extraction.
Ceramide-1-phosphate was extracted from Drosophila adults and
embryos following a previously described method [35]. C8-
ceramide-1-phosphate (Cayman Chemicals, Ann Arbor, Michi-
gan) was added as an internal standard. Lipid extracts were
transferred onto a C18 reverse phase column (Luna 5062m m
3 m, Phenomenex, Torrance, CA) equilibrated in 50% solvent A
(methanol:water:acetic acid 50:49:1) and 50% solvent B (metha-
nol:acetic acid 99:1). Both solvents contained 5 mM ammonium
acetate. Ceramide-1-phosphate molecular species were eluted at a
flow rate of 0.3 ml/min using a gradient from 50–100% solvent B
in solvent A in 15 min. Structural conformation was obtained by
positive electrospray ionization tandem mass spectrometry (ESI(+)-
MS/MS). Lipids were identified based on their specific precursor
and product ion pair and quantified using multiple monitoring as
previously described [36]. MRM transitions monitored were:
562.5/208.5 (d14:1/16:0), 590.5/208.5 (d14:1/18:0), 618.5/208.5
(d14:1/20:0), 646.5/208.5 (d14:1/22:0), 674.5:208.5 (d14:1/22:0).
Co-immunoprecipitation
WntD protein was purified as previously described; however,
the blue Sepharose fractions contained only WntD and bovine
serum albumin and were considered pure [37]. Further purifica-
tion steps were omitted.
IgG and Fz4::IgG proteins were purified as previously described
[38]. The Fz4::IgG construct is an Ig-tagged version of the cysteine
rich domain (CRD) of Fz4, which is the high-affinity Wnt-binding
cassette of Fz family members.
Protein G-coupled sepharose beads were incubated with equal
masses of purified IgG or Fz4::IgG protein overnight at 4uC.
Beads were washed with cold PBS and incubated with equal
amounts of purified WntD protein overnight at 4uC. Beads were
again washed with cold PBS. After washing, sample buffer was
added to beads and incubated 5 min at room temperature. All
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blot by standard protocols. Antibody dilutions: Rabbit anti-WntD
1:1000, AP-conjugated goat anti-Rabbit 1:20000 (Santa Cruz
Biotechnology, Santa Cruz, CA), AP-conjugated goat anti-human
1:20000 (Bio-Rad, Hercules, CA).
Supporting Information
Figure S1 Tissue-specific WntD antibody staining. WT
embryos stained with WntD antibody. A. Stage 8 embryo.
Expression is observed in invaginating midgut. B. Stage 14
embryo. Expression is observed in midgut (arrow) and gonads
(arrowheads).
(PDF)
Figure S2 Genetic crossing scheme for WntD suppres-
sor/enhancer screen. A–C. Deficiency stock virgin females
were mated to Act-Gal4/CyO; UASp-WntD/TM6B males and virgin
female progeny with no balancers were selected. These females,
overexpressing WntD in the germline and carrying a deficiency,
were mated to WT males and survival of progeny was assayed. A.
Scheme for X-chromosome deficiencies. B. Scheme for 2
nd
chromosome deficiencies. C. Scheme for 3
rd chromosome
deficiencies.
(PDF)
Figure S3 Imprecise excision of P-element in the Fz4
promoter region results in likely null alleles. A. Crossing
scheme to excise fz4
P{GSV2} P-element and recover potential Fz4
mutant alleles. B. Diagram of Fz4 locus. Grey boxes: 59 and 39
UTR. Black boxes: exons. fz4
P{GSV2} is inserted 64 bp upstream of
the Fz4 transcriptional start site and 217 bp upstream of the start
codon. White boxes indicate extent of major deletions of fz4
3-1
(2013 bp deletion) and fz4
25-1 (1042 bp deletion) alleles. C.
Southern blot of Fz4 excision alleles. Lane 1: WT. Lane 2:
fz4
P{GSV2}/Binsinscy. Lane 3:Homozygous fz4
P{GSV2}. Lane 7:fz4
3-1.
Band is shifted above expected size of 1.7 kb for intact P-element,
and below expected size of 7.8 kb for WT locus or a precise
excision, indicating a partial deletion of Fz4. Lane 42: fz4
25-1.B a n d
(visible above background in right-hand side of lane) appears to be
shifted slightly below expected size for WT locus, indicating partial
deletion of Fz4. All remaining lanes are uncharacterized excision
alleles and are homozygous, except for lanes 13 and 51, which are
balanced over Binsinscy.
(PDF)
Figure S4 Mutations in Ceramide kinases, but no other
lipid kinases, can suppress WntD overexpression.
Maternal WntD overexpression results in low survival of progeny.
Maternal WntD overexpression in flies carrying dcerk
P{GT1} results
in high survival of progeny. Maternal WntD overexpression in flies
carrying dgk
f03609, sk2
KG05894, or any of four different deficiencies
predicted to remove Sk1 results in low survival of progeny.
(PDF)
Figure S5 Dcerk and Dmulk display differential speci-
ficity for ceramide molecular species. A. Maternal Dcerk
and Dmulk overexpression results in increased embryonic C1P
levels compared to WT. Error bars represent SEM. Asterisks
represent P,0.05 by Student’s T-test compared to WT. Dcerk
overexpressor embryos are from a UASp-Dcerk/CyO; Act-Gal4/
TM6B incross. Dmulk overexpressor embryos are from a UASp-
Dmulk/CyO; Act-Gal4/TM6B incross. B. Measurements of
embryonic C1P level normalized to phosphatidylcholine levels,
+/2 standard deviation (SD).
(PDF)
Figure S6 Locations of EcoRI sites at the Fz4 locus.
EcoRI sites within the P{GSV2} P-element and flanking the
Southern blot probe (indicated by blue bar) at the Fz4 locus imply
predicted bands of 7.8 kb for a wild-type locus or precise P-
element excision; 1.7 kb for a locus with intact P-element, or in
which part of the P-element has been excised while the internal
EcoRI site remains inserted; 7.8–12.5 kb for a partial P-element
excision in which the internal EcoRI has been excised; or ,7.8 kb
for a deletion of the entire P-element plus surrounding Fz4
genomic DNA.
(PDF)
Table S1 Strong WntD pathway candidates from screen. High-
scoring candidates were narrowed by effects of overlapping
deficiencies, by virtue of association with GO terms consistent
with signaling pathways, significant change in expression by
microarray [5], and by maternal expression. ‘‘Total genes’’
indicates the number of genes in the region encompassed by the
deficiency, while ‘‘Remaining candidate genes’’ indicates the
number of genes after taking into account the phenotypes of other
overlapping deficiencies from the kit as well as smaller overlapping
deficiencies assayed after identification of the candidate regions.
The ‘‘WntD/yw’’ column indicates the fold difference in the
gene’s expression level in uninfected wntD
KO1 mutant adults
compared to uninfected yw adults, and ‘‘Listeria WntD/yw’’
indicates fold difference in the gene’s expression level in wntD
KO1
mutant adults compared to yw adults after injection with Listeria
monocytogenes [5]. Genes further characterized in this article are
indicated in bold.
(PDF)
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